Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
Top Cited Papers
- 1 November 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 11 (8) , 727-733
- https://doi.org/10.1097/00008571-200111000-00012
Abstract
A subpopulation of collie dogs is extremely sensitive to neurotoxicity induced by ivermectin. The aim of this study was to determine the mechanistic basis for this phenomenon. The multi-drug-resistance gene (mdr 1) encodes a large transmembrane protein, P-glycoprotein (P-gp), that is an integral part of the blood–brain barrier. P-gp functions as a drug-transport pump at the blood–brain barrier, transporting a variety of drugs from the brain back into the blood. Since ivermectin is a substrate for P-gp, we hypothesized that ivermectin-sensitive collies had altered mdr 1 expression compared with unaffected collies. We report a deletion mutation of the mdr 1 gene that is associated with ivermectin sensitivity. The 4-bp deletion results in a frame shift, generating several stop codons that prematurely terminate P-gp synthesis. Dogs that are homozygous for the deletion mutation display the ivermectin-sensitive phenotype, while those that are homozygous normal or heterozygous do not display increased sensitivity to ivermectin.Keywords
This publication has 23 references indexed in Scilit:
- Palindromic DNA and Genome Stability: Further StudiesaAnnals of the New York Academy of Sciences, 1999
- Changes in the use profile 1987-1997 of Mectizan:Pathogens and Global Health, 1998
- Identification of a P-Glycoprotein-Deficient Subpopulation in the CF-1 Mouse Strain Using a Restriction Fragment Length PolymorphismToxicology and Applied Pharmacology, 1997
- Immunohistochemical Detection of P-glycoprotein in Formalin-fixed and Paraffin-embedded Normal and Neoplastic Canine TissuesVeterinary Pathology, 1996
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- The Chemistry and Pharmacology of AvermectinsAnnual Review of Pharmacology and Toxicology, 1992
- Ivermectin: a review of efficacy and safetyJournal of Veterinary Pharmacology and Therapeutics, 1984